Cyclooxygenase-2 promotes cell proliferation, migration and invasion in U2OS human osteosarcoma cells |
Lee, Eun-Jeong
(Department of Biochemistry and Molecular Biology Kangwon National University College of Medicine)
Choi, Eun-Mi (Department of Biochemistry and Molecular Biology Kangwon National University College of Medicine) Kim, So-Ra (Department of Biochemistry and Molecular Biology Kangwon National University College of Medicine) Park, Jung-Hea (Department of Biochemistry and Molecular Biology Kangwon National University College of Medicine) Kim, Hyun-Sook (Department of Plant Biotechnology School of Bioscience and Biotechnology Kangwon National University) Ha, Kwon-Soo (Department of Biochemistry and Molecular Biology Kangwon National University College of Medicine) Kim, Young-Myeong (Department of Biochemistry and Molecular Biology Kangwon National University College of Medicine) Kim, Sung-Soo (Department of Pharmacology Kangwon National University College of Medicine) Choe, Myeon (Department of Plant Biotechnology School of Bioscience and Biotechnology Kangwon National University) Kim, Jong-Il (Department of Biochemistry and Molecular Biology Seoul National University College of Medicine) Han, Jeong-A (Department of Biochemistry and Molecular Biology Kangwon National University College of Medicine) |
1 | Fujita H, Koshida K, Keller ET, Takahashi Y, Yoshimito T, Namiki M, Mizokami A. Cyclooxygenase-2 promotes prostate cancer progression. Prostate 2002;53:232-40 DOI ScienceOn |
2 | Larkins TL, Nowell M, Singh S, Sanford GL. Inhibition of cyclooxygenase-2 decreases breast cancer cell motility, invasion and matrix metalloproteinase expression. BMC Cancer 2006;181:1-12 |
3 | Longhi A, Errani C, de Paolis M, Mercuri M, Bacci G. Primary bone osteosarcoma in the pediatric age: state of the art. Cancer Treat Rev 2006;32:423-36 DOI ScienceOn |
4 | Naruse T, Nishida Y, Hosono K, Ishiguro N. Meloxicam inhibits osteosarcoma growth, invasiveness and metastasis by COX-2-dependent and independent routes. Carcinogenesis 2006;27:584-92 DOI |
5 | Sanbino MA, Ghilardi JR, Jongen JL, Keyser CP, Luger NM, Mach DB, Peters CB, Rogers SD, Schwei MJ, de Felipe C, Mantyh PW. Simultaneous reduction in cancer pain, bone destruction, and tumor growth by selective inhibition of cyclooxygenase-2. Cancer Res 2002;62:7343-9 |
6 | Smith WL, Garavito RM, DeWitt DL. Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2. J Biol Chem 1996;271:33157-60 DOI ScienceOn |
7 | Xu Z, Choudhary S, Voznesensky O, Mehrotra M, Woodard M, Hansen M, Herschman H, Pilbeam C. Overexpression of COX-2 in human osteosarcoma cells decreases proliferation and increases apoptosis. Cancer Res 2006;66:6657-64 DOI ScienceOn |
8 | Li G, Yang T, Yan J. Cyclooxygenase-2 increased the angiogenic and metastatic potential of tumor cells. Biochem Biophys Res Commun 2002;299:886-90 DOI ScienceOn |
9 | Davies KJ. The broad spectrum of responses to oxidants in proliferating cells: a new paradigm for oxidative stress. IUBMB Life 1999;48:41-7 DOI |
10 | Han C, Wu T. Cyclooxygenase-2-derived prostaglandin promotes human cholangiocarcinoma cell growth and invasion through EP1 receptor-mediated activation of the epidermal growth factor receptor and Akt. J Biol Chem 2005;280:24053-63 DOI ScienceOn |
11 | Chen Q, Shinohara N, Abe T, Watanabe T, Nonomura K, Koyanagi T. Significance of COX-2 expression in human renal cell carcinoma cell lines. Int J Cancer 2004;108:825-32 DOI ScienceOn |
12 | Dickens DS, Kozielski R, Leavey PJ, Timmons C, Cripe TP, Cyclooxygenase-2 expression does not correlate with outcome in osteosarcoma or rhabdomyosarcoma. J Pediatr Hematol Oncol 2003;25:282-5 DOI ScienceOn |
13 | Liu CH, Chang SH, Narko K, Trifan OC, Wu MT, Smith E, Haudenschild C, Lane TF, Hla T. Overexpression of cyclooxygenase-2 is sufficient to induce tumorigenesis in transgenic mice. J Biol Chem 2001;276:18563-9 DOI ScienceOn |
14 | Klein G, Vellenga E, Fraaije MW, Kamps WA, de Bont ESJM. The possible role of matrix metalloproteinase (MMP)-2 and MMP-9 in cancer, e.g. acute leukemia. Crit Rev Oncol Hematol 2004;50:87-100 DOI ScienceOn |
15 | Klein RD, Pelt CSV, Sabichi AL, Cerda JD, Fischer SM, Furstenberger G, Muller-Decker K. Transitional cell hyperplasia and carcinomas in urinary bladders of transgenic mice with keratin 5 promoter-driven cyclooxygenase-2 overexpression. Cancer Res 2005;65:1808-13 DOI ScienceOn |
16 | Yoon SO, Yun CH, Chung AS. Dose effect of oxidative stress on signal transduction on aging. Mech Ageing Dev 2002; 123:1597-604 DOI ScienceOn |
17 | Krysan K, Reckamp KL, Dalwadi H, Sharma S, Rozengurt E, Dohadqala M, Dubinett SM. Prostaglandin activates mitogen-activated protein kinase/Erk pathway signaling and cell proliferation in non-small cell lung cancer cells in an epidermal growth factor receptor-independent manner. Cancer Res 2005;65:6275-81 DOI ScienceOn |
18 | Sheng H, Shao J, Washington MK, DuBois RN. Prostagladin increases growth and motility of colorectal carcinoma cells. J Biol Chem 2001;276:18075-81 DOI ScienceOn |
19 | Tsujii M, Kawano S, DuBois RN, Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc Natl Acad Sci USA 1997;94:3336-40 |
20 | Castellone MD, Teramoto H, Williams BO, Druey KM, Gutkind JS. Prostaglandin E2 promotes colon cancer cell growth through a signaling axis. Sience 2005;310:1504-10 DOI ScienceOn |
21 | Singh B, Berry JA, Shoher A, Ramakrishnan V, Lucci A. COX-2 overexpression increases motility and invasion of breast cancer cells. Int J Oncol 2005;26:1393-9 |
22 | Dickens DS, Kozielski R, Khan J, Forus A, Cripe TP. Cyclooxygenase-2 expression in pediatric sarcomas. Pediatr Dev Pathol 2002;5:356-64 DOI ScienceOn |